Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.
You have not selected any filters.
Focuses on assessment of anxiety disorders and evidence-based approaches to management. Both psychological and pharmacological treatment options will be discussed
Confidently recognise when low back pain requires further investigation and identify patients at risk of chronic, disabling pain.
Improve health outcomes for your patients with both type 2 diabetes and cardiovascular disease (CVD) by familiarising yourself with the latest CV outcome data and increasing your confidence to navigate management choices for the condition. This Clinical e-Audit requires data to be submitted for only SEVEN (7) patients. This program is funded by Boehringer Ingelheim Pty Limited and Eli Lilly Australia Pty Limited and managed through VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The program has been designed, developed and implemented by NPS MedicineWise with complete independence and editorial control and is based on best practice guidelines.
Review your PPI prescribing for patients with GORD and be guided on implementing an effective step-down approach for your patients.
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?